Esomeprazole In Patients With Gastric Acid Hypersecretory States Including Idiopathic Hypersecretion and Zollinger-Ellison Syndrome - Related Studies

Esomeprazole In Patients With Gastric Acid Hypersecretory States Including Idiopathic Hypersecretion and Zollinger-Ellison Syndrome

This study has been completed.

Study NCT00079833. Last updated on October 21, 2005. Information provided by AstraZeneca

Find Related Studies by Searching for the Conditions, Interventions, and Sponsors found in this study:


1	Conditions listed in this trial
		Zollinger-Ellison Syndrome

2	Additional conditions recognized in this trial
		Syndrome

3	More general conditions related to this trial
		Digestive System Diseases
		Digestive System Neoplasms
		Disease
		Gastrointestinal Diseases
		Gastrointestinal Neoplasms
		Intestinal Diseases
		Neoplasms
		Paraneoplastic Endocrine Syndromes
		Paraneoplastic Syndromes
		Pathologic Processes
		Peptic Ulcer
		Stomach Diseases

4	Interventions listed in this trial
		Esomeprazole magnesium

5	Additional drug interventions recognized in this trial
		Omeprazole

6	More general drug interventions related to this trial
		Anti-Ulcer Agents
		Enzyme Inhibitors
		Gastrointestinal Agents
		Molecular Mechanisms of Pharmacological Action
		Pharmacologic Actions
		Therapeutic Uses

7	Sponsors listed in this trial
		AstraZeneca